Effects of reduced endogenous 5‐HT on the in vivo binding of the serotonin transporter radioligand 11C‐DASB in healthy humans
暂无分享,去创建一个
Mark Slifstein | Marc Laruelle | Yiyun Huang | Yiyun Huang | D. Hwang | M. Laruelle | A. Abi-Dargham | M. Slifstein | R. Suckow | W. Frankle | P. Talbot | W. Gordon Frankle | Dah‐Ren Hwang | Peter S. Talbot | Anissa Abi‐Dargham | Raymond F. Suckow
[1] J. Mazziotta,et al. Rapid Automated Algorithm for Aligning and Reslicing PET Images , 1992, Journal of computer assisted tomography.
[2] Mark Slifstein,et al. Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography. , 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.
[3] Camellia P. Clark,et al. Clinical and Physiological Consequences of Rapid Tryptophan Depletion , 2000, Neuropsychopharmacology.
[4] R. V. Van Heertum,et al. Prefrontal Dopamine D1 Receptors and Working Memory in Schizophrenia , 2002, The Journal of Neuroscience.
[5] Latifa Rbah,et al. A reduced extracellular serotonin level increases the 5-HT1A PET ligand 18F-MPPF binding in the rat hippocampus. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] P. Plenge,et al. Regional distribution of the serotonin transport complex in human brain, identified with 3H-Paroxetine, 3H-Citalopram and 3H-Imipramine , 1990, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[7] Christer Halldin,et al. PET Studies of Binding Competition between Endogenous Dopamine and the D1 Radiotracer [11C]NNC 756 , 1998, NeuroImage.
[8] Alan A. Wilson,et al. Comparative Evaluation in Nonhuman Primates of Five PET Radiotracers for Imaging the Serotonin Transporters: [11C]McN 5652, [11C]ADAM, [11C]DASB, [11C]DAPA, and [11C]AFM , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[9] Christer Halldin,et al. Measurement of Striatal and Extrastriatal Dopamine D1 Receptor Binding Potential With [11C]NNC 112 in Humans: Validation and Reproducibility , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[10] Roger N. Gunn,et al. A Database of [11C]WAY-100635 Binding to 5-HT1A Receptors in Normal Male Volunteers: Normative Data and Relationship to Methodological, Demographic, Physiological, and Behavioral Variables , 2002, NeuroImage.
[11] D Hommer,et al. Effects of Acute Tryptophan Depletion on Plasma and Cerebrospinal Fluid Tryptophan and 5‐Hydroxyindoleacetic Acid in Normal Volunteers , 1999, Journal of neurochemistry.
[12] G. Gessa,et al. Brain dialysis and dopamine: does the extracellular concentration of dopamine reflect synaptic release? , 1990, European journal of pharmacology.
[13] Mark Slifstein,et al. Comparative evaluation of serotonin transporter radioligands 11C-DASB and 11C-McN 5652 in healthy humans. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] Alan A. Wilson,et al. Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB , 2000, European Journal of Nuclear Medicine.
[15] C. McDougle,et al. Tryptophan Depletion During Continuous CSF Sampling in Healthy Human Subjects , 1998, Neuropsychopharmacology.
[16] M. Folstein,et al. Reliability, validity, and clinical application of the visual analogue mood scale , 1973, Psychological Medicine.
[17] N. Zahniser,et al. Chronic and acute regulation of Na+/Cl- -dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. , 2001, Pharmacology & therapeutics.
[18] N. Simpson,et al. PET Studies of Binding Competition between Endogenous Dopamine and the D1 Radiotracer [11C]NNC 756 , 1998, NeuroImage.
[19] D E Kuhl,et al. Compartmental Analysis of [11C]Flumazenil Kinetics for the Estimation of Ligand Transport Rate and Receptor Distribution Using Positron Emission Tomography , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[20] Robert B. Innis,et al. SPECT Quantification of [123I]Iomazenil Binding to Benzodiazepine Receptors in Nonhuman Primates: I. Kinetic Modeling of Single Bolus Experiments , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[21] A. Beck,et al. An inventory for measuring depression. , 1961, Archives of general psychiatry.
[22] W. Riedel,et al. Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation , 1999, Psychopharmacology.
[23] F. Fadda,et al. Acute administration of a tryptophan-free amino acid mixture decreases 5-HT release in rat hippocampus in vivo. , 1997, The American journal of physiology.
[24] W. Riedel,et al. Mood effects of 24-hour tryptophan depletion in healthy first-degree relatives of patients with affective disorders , 1999, Biological Psychiatry.
[25] J. Seibyl,et al. SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: kinetic and equilibrium paradigms. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[26] John Hilton,et al. Comparison of (+)-(11)C-McN5652 and (11)C-DASB as serotonin transporter radioligands under various experimental conditions. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[27] P B Hoffer,et al. Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjects. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[28] Jan Pruim,et al. 5‐HT1A receptor imaging in the human brain: Effect of tryptophan depletion and infusion on [18F]MPPF binding , 2002 .
[29] H N Wagner,et al. A PET radiotracer for studying serotonin uptake sites: carbon-11-McN-5652Z. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[30] Jan Pruim,et al. 5-HT(1A) receptor imaging in the human brain: effect of tryptophan depletion and infusion on [(18)F]MPPF binding. , 2002, Synapse.
[31] Marc Laruelle,et al. The role of in vivo molecular imaging with PET and SPECT in the elucidation of psychiatric drug action and new drug development , 2002, European Neuropsychopharmacology.
[32] T Sandor,et al. An interactive procedure for extracting features of the brain from magnetic resonance images: The lobes , 1997, Human brain mapping.
[33] Susan Hume,et al. Fenfluramine evokes 5‐HT2A receptor‐mediated responses but does not displace [11C]MDL 100907: Small animal PET and gene expression studies , 2003, Synapse.
[34] R. Blakely,et al. Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins , 1998, Biological Psychiatry.
[35] M. Mintun,et al. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.
[36] P. Cowen,et al. Evidence that the large neutral amino acidl-valine decreases electrically-evoked release of 5-HT in rat hippocampus in vivo , 2005, Psychopharmacology.
[37] M. Laruelle. Imaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[38] R Myers,et al. Effect of 5‐HT on binding of [11C] WAY 100635 to 5‐HT1A receptors in rat brain, assessed using in vivo microdialysis and PET after fenfluramine , 2001, Synapse.
[39] Osama Mawlawi,et al. Imaging Human Mesolimbic Dopamine Transmission with Positron Emission Tomography: I. Accuracy and Precision of D2 Receptor Parameter Measurements in Ventral Striatum , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[40] M. Hariharan,et al. Systematic approach to the development of plasma amino acid analysis by high-performance liquid chromatography with ultraviolet detection with precolumn derivatization using phenyl isothiocyanate. , 1993, Journal of chromatography.
[41] J. Talairach,et al. Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System: An Approach to Cerebral Imaging , 1988 .
[42] Sylvain Houle,et al. Radiosynthesis of carbon‐11 labelled N‐methyl‐2‐(arylthio)benzylamines: potential radiotracers for the serotonin reuptake receptor , 1999 .
[43] F. Artigas,et al. Reduction of Serotonergic Function in Rat Brain by Tryptophan Depletion: Effects in Control and Fluvoxamine‐Treated Rats , 1996, Journal of neurochemistry.
[44] André Luxen,et al. Effect of endogenous serotonin on the binding of the 5‐HT1A PET ligand 18F‐MPPF in the rat hippocampus: kinetic β measurements combined with microdialysis , 2002, Journal of neurochemistry.
[45] M. Laruelle,et al. Vulnerability of positron emission tomography radiotracers to endogenous competition. New insights. , 2001, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.
[46] J. Marcusson,et al. High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue , 1989, Brain Research.
[47] Marc Laruelle,et al. Regional and subcellular localization in human brain of [3H]paroxetine binding, a marker of serotonin uptake sites , 1988, Biological Psychiatry.
[48] S. Houle,et al. Novel Radiotracers for Imaging the Serotonin Transporter by Positron Emission Tomography: Synthesis, Radiosynthesis, and in Vitro and ex Vivo Evaluation of (11)C-Labeled 2-(Phenylthio)araalkylamines. , 2000, Journal of medicinal chemistry.
[49] R. Parsey,et al. PET Studies of Binding Competition Between Endogenous Dopamine and the D 1 , 1999 .
[50] S. Zoghbi,et al. Evaluation of ultrafiltration for the free-fraction determination of single photon emission computed tomography (SPECT) radiotracers: beta-CIT, IBF, and iomazenil. , 1994, Journal of pharmaceutical sciences.
[51] T Suhara,et al. In vivo binding properties of [carbonyl‐11C]WAY‐100635: Effect of endogenous serotonin , 2001, Synapse.
[52] E. Cabanis,et al. The Human Brain: Surface, Three-Dimensional Sectional Anatomy and Mri , 1991 .
[53] Nora D Volkow,et al. Effects of Endogenous Neurotransmitters on the in vivo Binding of Dopamine and 5-HT Radiotracers in Mice , 2001, Neuropsychopharmacology.
[54] Sylvain Houle,et al. In vitro and in vivo characterisation of [11C]-DASB: a probe for in vivo measurements of the serotonin transporter by positron emission tomography. , 2002, Nuclear medicine and biology.
[55] E. Metzger,et al. Comparison of the effects of amino acid mixture and placebo on plasma tryptophan to large neutral amino acid ratio. , 1995, Life sciences.
[56] Alan A. Wilson,et al. Positron Emission Tomography Quantification of [11C]-DASB Binding to the Human Serotonin Transporter: Modeling Strategies , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[57] Allan L. Reiss,et al. Reliability and validity of MRI measurement of the amygdala and hippocampus in children with fragile X syndrome , 1997, Psychiatry Research: Neuroimaging.
[58] W. Riedel,et al. Mood congruent memory bias induced by tryptophan depletion , 2002, Psychological Medicine.
[59] John Hilton,et al. Comparison of (+)-11C-McN5652 and 11C-DASB as Serotonin Transporter Radioligands Under Various Experimental Conditions , 2002 .